Q1UE34.SA Quest Diagnostics Incorporated

Healthcare Diagnostics & Research Sao Paulo Exchange
579.60 BRL
Close of Nov 5, 2026
474.32 612.15
Market cap
BRL 128B
P/E
22.1x
P/B
3.08x
ROE
15.4%
Dividend yield
1.05%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is Q1UE34.SA undervalued?

Graham number
Price579.60
Graham value332.95
Premium74.1%

Q1UE34.SA trades 74.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Quest Diagnostics Incorporated fundamental analysis

No fundamental analysis for Quest Diagnostics Incorporated yet.

Quest Diagnostics Incorporated stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consum…

Full company profile